Tiziana Life Sciences Ltd

TLSA ·Healthcare, Drug Manufacturers - General, United Kingdom
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $3.7M $1.2M $18.1M $42.2M $65.8M $200.0K $5.3M $64.0K
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $7.5M $7.3M $24.3M $48.7M $70.2M $1.5M $6.9M $2.4M
Property, Plant & Equipment — — — — — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $11.3M $12.2M $26.5M $48.8M $70.7M $2.4M $6.9M $2.5M
Liabilities
Accounts Payable $5.6M $4.1M $5.0M $4.4M $3.4M $4.2M $3.6M $4.4M
Total Current Liabilities $7.3M $6.5M $6.7M $7.5M $8.0M $7.4M $6.4M $4.7M
Long-Term Debt — — — — — — — —
Total Liabilities $7.3M $6.6M $6.9M $7.5M $8.3M $-67.3M $-68.8M $4.7M
Stockholders' Equity
Retained Earnings $-144.8M $-133.7M $-116.3M $-108.1M $-84.6M $-60.0M $-50.7M $-42.6M
Total Stockholders' Equity $3.9M $5.5M $19.6M $41.3M $62.4M $69.6M $75.8M $-2.3M